Literature DB >> 24825588

Flexible sequential designs for multi-arm clinical trials.

D Magirr1, N Stallard, T Jaki.   

Abstract

Adaptive designs that are based on group-sequential approaches have the benefit of being efficient as stopping boundaries can be found that lead to good operating characteristics with test decisions based solely on sufficient statistics. The drawback of these so called 'pre-planned adaptive' designs is that unexpected design changes are not possible without impacting the error rates. 'Flexible adaptive designs' on the other hand can cope with a large number of contingencies at the cost of reduced efficiency. In this work, we focus on two different approaches for multi-arm multi-stage trials, which are based on group-sequential ideas, and discuss how these 'pre-planned adaptive designs' can be modified to allow for flexibility. We then show how the added flexibility can be used for treatment selection and sample size reassessment and evaluate the impact on the error rates in a simulation study. The results show that an impressive overall procedure can be found by combining a well chosen pre-planned design with an application of the conditional error principle to allow flexible treatment selection.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adaptive designs; closed testing; combination test; conditional error; multi-arm

Mesh:

Year:  2014        PMID: 24825588     DOI: 10.1002/sim.6183

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  13 in total

1.  The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  BMJ       Date:  2020-06-17

Review 2.  Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making.

Authors:  Thomas M Caparrotta; James W Dear; Helen M Colhoun; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2019-07-24       Impact factor: 4.335

3.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

4.  Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.

Authors:  Nigel Stallard; Cornelia Ursula Kunz; Susan Todd; Nicholas Parsons; Tim Friede
Journal:  Stat Med       Date:  2015-06-26       Impact factor: 2.373

5.  Multi-arm group sequential designs with a simultaneous stopping rule.

Authors:  S Urach; M Posch
Journal:  Stat Med       Date:  2016-08-23       Impact factor: 2.373

6.  Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments.

Authors:  Thomas Jaki; Despina Vasileiou
Journal:  Stat Med       Date:  2016-11-02       Impact factor: 2.373

7.  Early phase and adaptive design clinical trials in rheumatoid arthritis: a systematic review of early phase trials.

Authors:  Tim Pickles; Robin Christensen; Lai-Shan Tam; Lee S Simon; Ernest H Choy
Journal:  Rheumatol Adv Pract       Date:  2018-10-17

8.  The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  Trials       Date:  2020-06-17       Impact factor: 2.279

9.  Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.

Authors:  Thomas Jaki; Lisa V Hampson
Journal:  Stat Med       Date:  2015-10-12       Impact factor: 2.373

10.  Adaptive multiarm multistage clinical trials.

Authors:  Pranab Ghosh; Lingyun Liu; Cyrus Mehta
Journal:  Stat Med       Date:  2020-02-11       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.